SLC31A1 and triple-negative breast carcinoma: CTR1 expression was significantly higher in triple-negative breast cancer (TNBC) non-responders than responders (P = 0.0021), particularly in grade 3 tumors (P = 0.0035), with no difference in luminal subtypes.